Skip to content

Lawyers
Corey McClary listen

About

Corey* is an associate at Lenczner Slaght specializing in intellectual property law. With a Ph.D. in organic chemistry and experience litigating a broad range of complex matters in the pharmaceutical and life sciences industries, Corey brings his technical expertise, unique perspective, and positive attitude to every case he works on. Whether it's synthesizing scientific concepts into clear and concise language for the courts or developing novel legal strategies, Corey knows§ how to innovate and leverage his creativity and depth of knowledge to overcome challenges and develop winning strategies for his clients. You can count on Corey to know what it takes to deliver the best results. .

Expertise

  • Practice Areas:
  • Bar Admissions:
    • Ontario (2017)
  • Education:
    • Osgoode Hall Law School (2016) JD
    • University of Toronto (2013) PhD (Chemistry)
    • Memorial University of Newfoundland (2008) BSc (Chemistry)

Details

Corey McClary (he/him)

is an associate at Lenczner Slaght.

Corey's practice is primarily focused on intellectual property law, with an emphasis on pharmaceutical patent litigation. Corey has experience advising clients on complex disputes, including actions under the Patented Medicines (Notice of Compliance) Regulations, patent infringement and impeachment actions, and judicial review proceedings. Corey also regularly provides strategic patent and regulatory advice.

Prior to joining Lenczner Slaght, Corey summered, articled and practiced in the intellectual property litigation group at a leading international law firm in Toronto.

Before attending law school, Corey obtained a Ph.D. in organic chemistry. His graduate research focused on developing methods for the regioselective functionalization of carbohydrates and measuring the strength of non-covalent interactions. His research has been published in peer-reviewed scientific journals.

Show more
  • Toronto Intellectual Property Group

  • Ontario Bar Association

  • Fall Regulatory Round Up – The Shifting Shape of the Canadian Landscape

    Fall Regulatory Round Up

    Activity abounds on the regulatory landscape from modernization and transparency initiatives to consultations, collaborations, and even potential implementations. Our Fall Regulatory Round Up highlights significant developments for drug products and patents that are of interest to those in the life sciences and biotech spaces. We will be following these important regulatory initiatives as they continue to unfold and will provide updates of interest.

    Cynthia L. Tape, Jordana Sanft & Corey McClary | September 30, 2024

scroll
Back to top